Teleflex wins expanded FDA clearance for PAD device

08/2/2013 | (Boston)

The FDA has granted Teleflex clearance for new versions of its Arrow GPSCath Balloon Dilatation Catheter that have 80-centimeter lengths and higher burst-pressure ratings. The device, which was acquired by Teleflex through its acquisition of Hotspur Technologies last year, is used to treat patients with peripheral artery disease.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA